| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 05/03/2000 | CN1251773A Composition having silicone rubber stabilized ascorbic acid components |
| 05/03/2000 | CN1251768A Chinese medicine for treating burn and scald and its preparing process |
| 05/03/2000 | CN1251767A Chinese medicine and Western medicine compounded preparation for dropping drug |
| 05/03/2000 | CN1251764A Exterior-applied ointment for treating rheumatic arthritis |
| 05/03/2000 | CN1251763A Process for preparing Chinese medicine 'Qianjin tablets' for treating gynopathy |
| 05/03/2000 | CN1251762A Process for preparing Chinese medicine 'Buxueyimu Particles' |
| 05/03/2000 | CN1251760A Medicine |
| 05/03/2000 | CN1251758A Oral medicinal preparation |
| 05/03/2000 | CN1251745A Carotenoid preparation having mixture of beta-carotene, lycopene and xanthophyll |
| 05/03/2000 | CN1051937C Algefacient and anthypnotic aerosol for driver |
| 05/03/2000 | CN1051936C Quick-action defatting liquid and its preparing method |
| 05/03/2000 | CN1051935C Chinese herbal medicine for senile dementia and preparation thereof |
| 05/03/2000 | CN1051932C Drug for acne and its preparation |
| 05/03/2000 | CN1051930C Use of sea-buckthorn fruit oil in medicine for regulating endocrine function of women |
| 05/03/2000 | CN1051927C Navel medicine bag for treatment of hypertension and cerebral arteriosclerosis and preparation |
| 05/03/2000 | CN1051925C Capsule preparation for pile |
| 05/03/2000 | CN1051922C Formulation comprising antibacterial substance and anticancer substance |
| 05/03/2000 | CN1051919C Depigmenting composition for the simultaneous treatment of surface layers and deep layers of skin, and use thereof |
| 05/02/2000 | US6057374 Composition, device, and method for electrotransport agent delivery |
| 05/02/2000 | US6057359 Spontaneously dispersible concentrates comprising esters of baccatin-III compounds having antitumor and antiviral activity |
| 05/02/2000 | US6057307 Use of mometasone furoate for treating airway passage and lung diseases |
| 05/02/2000 | US6057301 Moisture resistant, improved storage stability |
| 05/02/2000 | US6057139 Preparing enzyme tablets for the treatment of lactose defects |
| 05/02/2000 | US6057096 Photocleavable agents and conjugates for the detection and isolation of biomolecules |
| 05/02/2000 | US6056977 Once-a-day controlled release sulfonylurea formulation |
| 05/02/2000 | US6056976 Elastomer, its preparation and use |
| 05/02/2000 | US6056975 Levothyroxine sodium, polysaccharide |
| 05/02/2000 | US6056974 Rapid-release S1452 tablets |
| 05/02/2000 | US6056973 Therapeutic liposome composition and method of preparation |
| 05/02/2000 | US6056971 Coenzyme q(ubiquinone), orally delivered soft gelatin capsule, nonionic surfactant solubilizer with a polyhydric alcohol |
| 05/02/2000 | US6056968 Pharmaceutical drug dosage forms providing different release rates |
| 05/02/2000 | US6056966 Organic mono- or dinitrate in a pharmaceutically acceptable topical or parenteral carrier |
| 05/02/2000 | US6056955 Topical treatment of streptococcal infections |
| 05/02/2000 | US6056954 Treatment of skin infections, wounds, and burns, eye infections |
| 05/02/2000 | US6056950 Ophthalmic solutions viscosified with tamarind seed polysaccharide |
| 05/02/2000 | US6056949 Aromatic granulated material |
| 05/02/2000 | US6056945 Compositions containing silicone-grafted polymer and thickening polymer of (meth)acrylamide derivative |
| 05/02/2000 | US6056943 Methods of ultrasound imaging using phospholipid stabilized microbubbles |
| 05/02/2000 | US6056938 Cationic lipids and the use thereof |
| 05/02/2000 | US6056791 Dissolving materials in pressurized compressible fluids at temperatures below decomposition temperature, then rapid cooling and decompression causes precipitation, for materials which decompose before they melt when heated |
| 05/02/2000 | US6055980 Dry powder inhaler |
| 05/02/2000 | CA2184242C Drug targeting system, method for preparing same and its use |
| 05/02/2000 | CA2137176C Liponucleotide compounds |
| 05/02/2000 | CA2136411C Immediate release tablet cores of insoluble drugs having sustained release coating |
| 05/02/2000 | CA2104686C Delayed release oral dosage forms for treatment of intestinal disorders |
| 05/02/2000 | CA2076018C Docosahexaenoic acid, methods for its production and compounds containing the same |
| 05/02/2000 | CA2011684C Aqueous film coating |
| 04/27/2000 | WO2000023601A1 Delivery system for porcine somatotropin |
| 04/27/2000 | WO2000023592A2 Minimal promoters and uses thereof |
| 04/27/2000 | WO2000023569A1 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema |
| 04/27/2000 | WO2000023460A1 HIGH PURITY COMPOSITION COMPRISING (7α,17α)- 17-HYDROXY- 7-METHYL- 19-NOR-17-PREGN- 5(10)-EN-20-YN-3-ONE |
| 04/27/2000 | WO2000023115A1 TREATMENT OF TRAUMA (I.E. GRAFT REJECTION) WITH LIPOSOMES CONTAINING DNA ENCODING FOR CTLA4Ig OR FOR ANTI-CD40L |
| 04/27/2000 | WO2000023113A1 Peptide-based carrier devices for stellate cells |
| 04/27/2000 | WO2000023104A1 Freeze-dried hepatitis a attenuated live vaccine and its stabilizer |
| 04/27/2000 | WO2000023099A1 Insulin preparations for pulmonary delivery containing menthol |
| 04/27/2000 | WO2000023098A1 Stable concentrated insulin preparations for pulmonary delivery |
| 04/27/2000 | WO2000023086A2 Buffered compositions for dialysis |
| 04/27/2000 | WO2000023079A1 Oral pharmaceutical compositions containing buprenorphin |
| 04/27/2000 | WO2000023077A1 Method for treating schizophrenia and means used in said method |
| 04/27/2000 | WO2000023068A2 Fumaric acid microtablets |
| 04/27/2000 | WO2000023065A2 Storable active substance concentrate with formoterol |
| 04/27/2000 | WO2000023055A1 Oral pulsed dose drug delivery system |
| 04/27/2000 | WO2000023054A1 Polyvinyl alcohol microspheres, and methods for making and therapeutic uses of the same |
| 04/27/2000 | WO2000023052A1 Liposome-entrapped topoisomerase inhibitors |
| 04/27/2000 | WO2000023051A1 Aerosol ointment compositions and method of manufacture |
| 04/27/2000 | WO2000023050A1 Propofol composition comprising pentetate |
| 04/27/2000 | WO2000023049A1 Micelles containing a hydrophobic phase on the interior and a glycoprotein exterior |
| 04/27/2000 | WO2000023048A1 Perfusate preparation for ophthalmic operation |
| 04/27/2000 | WO2000023046A1 Chewable or dissolvable pharmaceutical compositions suitable for oral administration |
| 04/27/2000 | WO2000023045A1 Pharmaceutical composition with gastric residence and controlled release |
| 04/27/2000 | WO2000023037A1 Two chamber cartridge for atomizers |
| 04/27/2000 | WO2000023023A1 Methods of hydrating mucosal surfaces |
| 04/27/2000 | WO2000023022A1 Method and compositions for in situ formation of protective and/or medicated films on body tissue |
| 04/27/2000 | WO2000022909A2 Systems for oral delivery |
| 04/27/2000 | WO2000006132A3 Pharmaceutical formulations comprising beclomethasone dipropionate for the treatment of inflammatory bowel disease |
| 04/27/2000 | WO2000004920A3 Method of vaccination of newly hatched poultry |
| 04/27/2000 | WO2000004894A3 Treatment regimen for administration of phenylacetylglutamine, phenylacetylisoglutamine, and/or phenylacetate |
| 04/27/2000 | WO2000003683A3 Liposomal encapsulated nucleic acid-complexes |
| 04/27/2000 | WO1999065540A9 Medical infusion device with a source of controlled compliance |
| 04/27/2000 | WO1999065531A9 Polymers for delivery of nucleic acids |
| 04/27/2000 | WO1999065460A3 Pressurized metered dose inhalers and pharmaceutical aerosol formulations comprising a beta-agonist |
| 04/27/2000 | WO1999060095A3 Formation and metallization of high aspect ratio lipid microtubules |
| 04/27/2000 | WO1999059545A9 Targeted liposomal drug delivery system |
| 04/27/2000 | DE19848856A1 Topically applied film-forming composition containing antiandrogenic N-phenyl-azolidine compound, used for treating hirsutism, seborrhea, acne or especially androgenetic alopecia |
| 04/27/2000 | DE19848849A1 Free-flowing, homogeneous spheres of active agent, e.g. drug, in auxiliary matrix, obtained by dropping molten mixture from nozzle into fluid for freezing and solidification |
| 04/27/2000 | DE19827178A1 Stable aerosol formulations containing two or more bioactives used for pharmaceuticals |
| 04/27/2000 | CA2773698A1 Adjuvant systems comprising an immunostimulant adsorbed to a metallic salt particle and vaccines thereof |
| 04/27/2000 | CA2749553A1 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema |
| 04/27/2000 | CA2622786A1 Neovascular-specific peptides |
| 04/27/2000 | CA2347921A1 Preparation of irrigating solution for ocular surgery |
| 04/27/2000 | CA2347369A1 Minimal promoters and uses thereof |
| 04/27/2000 | CA2347118A1 Propofol composition comprising pentetate |
| 04/27/2000 | CA2347108A1 Aerosol ointment compositions and method of manufacture |
| 04/27/2000 | CA2346969A1 Stable concentrated insulin preparations for pulmonary delivery |
| 04/27/2000 | CA2346884A1 Insulin preparations for pulmonary delivery containing menthol |
| 04/27/2000 | CA2346879A1 Liposome-entrapped topoisomerase inhibitors |
| 04/27/2000 | CA2346799A1 Delivery system for porcine somatotropin |
| 04/27/2000 | CA2346656A1 Methods of hydrating mucosal surfaces |
| 04/27/2000 | CA2345205A1 Polyvinyl alcohol microspheres, and methods for making and therapeutic uses of the same |
| 04/27/2000 | CA2341855A1 Method for treating schizophrenia, and means for use in this method |